phosphotyrosine has been researched along with phosphatidylinositol 4-phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baggio, B; Bordin, L; Clari, G; Moret, V | 1 |
| Arcaro, A; Domin, J; Ullrich, A; Wallasch, C; Waterfield, MD; Zvelebil, MJ | 1 |
2 other study(ies) available for phosphotyrosine and phosphatidylinositol 4-phosphate
| Article | Year |
|---|---|
Tyrosine-protein kinase inhibition in human erythrocytes by polyphosphoinositides (PIP and PIP2).
Topics: Adenosine Triphosphate; Anion Exchange Protein 1, Erythrocyte; Chymotrypsin; Erythrocytes; Humans; Hydrogen-Ion Concentration; Peptide Fragments; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylinositols; Phosphoserine; Phosphotyrosine; Protein-Tyrosine Kinases; Tyrosine | 1992 |
Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.
Topics: Binding Sites; Calcium; Epidermal Growth Factor; ErbB Receptors; Humans; Phosphates; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphotyrosine; Platelet-Derived Growth Factor; Receptor, ErbB-2; Receptors, Platelet-Derived Growth Factor; Tumor Cells, Cultured | 2000 |